Source:http://linkedlifedata.com/resource/pubmed/id/19885578
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
2009-11-3
|
pubmed:abstractText |
Matrix metalloproteinases (MMPs) secreted by lung cancer (LC) and malignant mesothelioma (MM), especially MMP-2 and MMP-9, play crucial roles in tumor invasion and metastasis. We examined the effect of cytokines, mitogens and inhibitors on MMP-2 and MMP-9 expression in LC and MM cell lines. Human LC (A-549) and MM (MSTO-211H) cell lines were cultured in appropriate media. At near confluence, the cells were washed with PBS and incubated in serum-free medium with various concentrations of several cytokines, mitogens and inhibitors. After 24 h the media were removed and analyzed for MMP-2 and MMP-9 by gelatinase zymography and quantitated by densitometry. LC expressed MMP-2 whereas MM expressed MMP-2 and MMP-9. TNF-alpha, IL-1beta, LPS and PMA, stimulated MMP-2 in LC and inhibited MMP-2 in MM, but had no effect on MMP-9. Doxycycline, EGCG and NM inhibited MMP-2 and MMP-9 expression, in both cell lines. Actinomycin-D, cyclohexamide, retinoic acid and dexamethasone inhibited MMP-2 in both cancer cell lines and inhibited MMP-9 in MM. Our results show that cytokines and inhibitors have an up- or down-regulatory effect on MMP-2 and MMP-9 expression in LC and MM, suggesting the clinical value of targeting these proteases for management of LC and MM and their pathogenesis.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Culture Media,
http://linkedlifedata.com/resource/pubmed/chemical/Cytokines,
http://linkedlifedata.com/resource/pubmed/chemical/Lipopolysaccharides,
http://linkedlifedata.com/resource/pubmed/chemical/Matrix Metalloproteinase 2,
http://linkedlifedata.com/resource/pubmed/chemical/Matrix Metalloproteinase 9,
http://linkedlifedata.com/resource/pubmed/chemical/Tetradecanoylphorbol Acetate
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
1791-2431
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
22
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1283-91
|
pubmed:meshHeading |
pubmed-meshheading:19885578-Antineoplastic Agents,
pubmed-meshheading:19885578-Cell Line, Tumor,
pubmed-meshheading:19885578-Culture Media,
pubmed-meshheading:19885578-Cytokines,
pubmed-meshheading:19885578-Gene Expression Regulation, Enzymologic,
pubmed-meshheading:19885578-Gene Expression Regulation, Neoplastic,
pubmed-meshheading:19885578-Humans,
pubmed-meshheading:19885578-Lipopolysaccharides,
pubmed-meshheading:19885578-Lung Neoplasms,
pubmed-meshheading:19885578-Matrix Metalloproteinase 2,
pubmed-meshheading:19885578-Matrix Metalloproteinase 9,
pubmed-meshheading:19885578-Mesothelioma,
pubmed-meshheading:19885578-Neoplasm Metastasis,
pubmed-meshheading:19885578-Tetradecanoylphorbol Acetate,
pubmed-meshheading:19885578-Time Factors
|
pubmed:year |
2009
|
pubmed:articleTitle |
Modulation of MMP-2 and MMP-9 by cytokines, mitogens and inhibitors in lung cancer and malignant mesothelioma cell lines.
|
pubmed:affiliation |
Dr Rath Research Institute, Santa Clara, CA 95050, USA.
|
pubmed:publicationType |
Journal Article
|